Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 801-808

  Vicha, Ales ^a   Holzerova, Milena ^b   Krepelova, Anna ^a   Musil, Zdenek ^a,c   Prochazka, Pavel ^a   Sumerauer, David ^a   Kodet, Roman ^a   Eckschlager, Tomas ^a   Jarosova, Marie ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Comparative genomic hybridization; Microarray; Paraganglioma; Pediatric; Pheochromocytoma

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ARTICLE; CANCER SURGERY; CARCINOGENESIS; CASE REPORT; CHILD HEALTH; CHROMOSOME 11; CHROMOSOME 11P; CHROMOSOME 1P; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; FOLLOW UP; GAIN OF FUNCTION MUTATION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOSS OF FUNCTION MUTATION; MALE; PHEOCHROMOCYTOMA; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; VON HIPPEL-LINDAU DISEASE;

EID: 84855417508     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9385-8     Document Type: Article

References (33)

1. Havekes B, Romijn JA, Eisenhofer G et al (2009) Update on pediatric pheochromocytoma. Pediatr Nephrol 24:943-950
2. Lenders JW, Eisenhofer G, Mannelli M et al (2005) Phaeochromocytoma. Lancet 366:665-675 (Pubitemid 41176020)
3. Lemeta S, Salmenkivi K, Pylkkanen L et al (2006) Frequent loss of heterozygosity at 6q in pheochromocytoma. Hum Pathol 37:749-754 (Pubitemid 43956547)
4. Ciftci AO, Tanyel FC, Senocak ME et al (2001) Pheochromocytoma in children. J Pediatr Surg 36:447-452 (Pubitemid 32193735)
5. Ross JH (2000) Pheochromocytoma. Special considerations in children. Urol Clin North Am 27:393-402
6. Caty MG, Coran AG, Geagen M et al (1990) Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg 125:978-981 (Pubitemid 20249332)
7. Eisenhofer G, Bornstein SR, Brouwers FM et al (2004) Malignant pheochromocytoma: Current status and initiatives for future progress. Endocr Relat Cancer 11:423-436 (Pubitemid 39331275)
8. Huang H, Abraham J, Hung E et al (2008) Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: Recommendation from a 22-year follow-up of 18 patients. Cancer 113:2020-2028
9. De Krijger RR, Petri BJ, Van Nederveen FH et al (2006) Frequent genetic changes in childhood pheochromocytomas. Ann NY Acad Sci 1073:166-176 (Pubitemid 44912009)
10. Astuti D, Latif F, Dallol A et al (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49-54 (Pubitemid 32614017)
11. Mannelli M, Simi L, Gagliano MS et al (2007) Genetics and biology of pheochromocytoma. Exp Clin Endocrinol Diabetes 115:160-165 (Pubitemid 46640282)
12. Neumann HP, Berger DP, Sigmund G et al (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel- Lindau disease. N Engl J Med 329:1531-1538 (Pubitemid 23332438)
13. Eng C, Crossey PA, Mulligan LM et al (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J Med Genet 32:934-937
14. Erlic Z, Neumann HP (2009) Familial pheochromocytoma. Hormones (Athens) 8:29-38
15. McNicol AM, Young WF Jr., Kawashma A, Komminoth P, Tischler AS (2004) Benign phaeochromocytoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds). WHO classification of tumours: Pathology and genetics of tumours of endocrine organs. Lyon7 International Agency for Research on Cancer (IARC) 151-5
16. Medeiros LJ, Wolf BC, Balogh K et al (1985) Adrenal pheochromocytoma: A clinicopathologic review of 60 cases. Hum Pathol 16:580-589 (Pubitemid 15049632)
17. Werbel SS, Ober KP (1995) Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am 79:131-153
18. Adjalle R, Plouin PF, Pacak K et al (2009) Treatment of malignant pheochromocytoma. Horm Metab Res 41:687-696
19. Dannenberg H, Speel EJ, Zhao J et al (2000) Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. Am J Pathol 157:353-359 (Pubitemid 30626902)
20. Edstrom E, Mahlamaki E, Nord B et al (2000) Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 156:651-659 (Pubitemid 30643820)
21. Hering A, Guratowska M, Bucsky P et al (2006) Characteristic genomic imbalances in pediatric pheochromocytoma. Genes Chromosom Cancer 45:602-607 (Pubitemid 43727167)
22. Lui WO, Chen J, Glasker S et al (2002) Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome. Oncogene 21:1117-1122 (Pubitemid 34174524)
23. Musil Z, Puchmajerova A, Krepelova A, et al. Paraganglioma in a 13-year-old girl: A novel SDHB gene mutation in the family? Cancer Genet Cytogenet 197:189-92
24. Bedrnicek J, Vicha A, Jarosova M et al (2005) Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization. Neoplasma 52:415-419 (Pubitemid 41406690)
25. Hofstra RM, Wu Y, Stulp RP et al (2000) RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 15:418-429 (Pubitemid 30331214)
26. Petri BJ, Speel EJ, Korpershoek E et al (2008) Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas. Mod Pathol 21:407-413 (Pubitemid 351441028)
27. van Nederveen FH, Korpershoek E, deLeeuw RJ et al (2009) Array-comparative genomic hybridization in sporadic benign pheochromocytomas. Endocr Relat Cancer 16:505-513
28. Khosla S, Patel VM, Hay ID et al (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699
29. Hensen EF, Jordanova ES, van Minderhout IJ et al (2004) Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23:4076-4083 (Pubitemid 38747938)
30. Burkhardt B,Moericke A, KlapperWet al (2008) Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leuk Lymphoma 49:451-461 (Pubitemid 351298328)
31. Nakano M, Takahashi H, Shiraishi T et al (2008) Prediction of clinically insignificant prostate cancer by detection of allelic imbalance at 6q, 8p and 13q. Pathol Int 58:415-420 (Pubitemid 351814373)
32. Speel EJ, Richter J, Moch H et al (1999) Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 155:1787-1794
33. August C, August K, Schroeder S et al (2004) CGH and CD 44/ MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas. Mod Pathol 17:1119-1128 (Pubitemid 39128238)